ALERT - AHA, FDA Encourage Conservation of Small-Volume Parenteral Medication During Shortage




The U.S. Food and Drug Administration and the American Hospital Association have issued alerts to members and providers regarding guidelines for addressing the national shortage of Small-Volume Parenteral Solutions including suggestions for management and conservation.  
Hospitals and health systems are experiencing shortages of intravenous (IV) fluids that are critical to patient care. These national shortages were triggered by several factors, including continued pharmaceutical market consolidation and production interruptions at some manufacturing facilities due to serious quality issues. These shortages have worsened dramatically as a result of Hurricane Maria’s impact on manufacturing plants in Puerto Rico. The most significant and severe shortage is for small-volume parenteral solutions, such as the 50 and 100 milliliter “minibags” of sodium chloride 0.9%, dextrose 5% and IV nutritional products made by Baxter.
FDA is working with Baxter and other drug companies to reduce the impact of these shortages and to restore operations of Baxter facilities in Puerto Rico. Most recently, FDA has permitted Baxter to import supplies of these products from their plants in Ireland, Australia, Mexico and Canada. However, the imported supplies are not expected to fully address existing shortages of these products. These shortages are not expected to be resolved for several months.
We encourage hospitals to periodically check the FDA drug shortage website for updated information regarding these shortages, including expected duration and available alternatives. For additional information, hospitals also can contact the manufacturers of these products directly.
© 2018 The Ohio Hospital Association. All Rights Reserved.